Holen Sie sich die Stockscreener-App
360.54
0.78%
2.78
Handel nachbörslich:
360.54
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$357.76
Offen:
$358.34
24-Stunden-Volumen:
1.06M
Relative Volume:
1.03
Marktkapitalisierung:
$35.40B
Einnahmen:
$3.77B
Nettoeinkommen (Verlust:
$449.25M
KGV:
45.90
EPS:
7.8556
Netto-Cashflow:
$240.68M
1W Leistung:
-2.86%
1M Leistung:
+9.51%
6M Leistung:
-4.75%
1J Leistung:
+3.66%
1-Tages-Spanne:
$354.11
$367.96
1-Wochen-Bereich:
$353.63
$377.50
52-Wochen-Spanne:
$275.05
$414.15
Waters Corp Stock (WAT) Company Profile
Firmenname
Waters Corp
Sektor
Branche
Telefon
(508) 478-2000
Adresse
34 MAPLE ST, MILFORD, MA
Compare WAT vs TMO, DHR, IDXX, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
360.54 | 35.13B | 3.77B | 449.25M | 240.68M | 7.8556 |
TMO
Thermo Fisher Scientific Inc
|
472.63 | 176.04B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
181.35 | 128.18B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
573.00 | 44.96B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
128.34 | 36.88B | 7.23B | 1.41B | 1.09B | 4.979 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2026-02-10 | Fortgesetzt | Barclays | Overweight |
| 2026-02-10 | Fortgesetzt | Citigroup | Buy |
| 2026-02-10 | Fortgesetzt | Evercore ISI | In-line |
| 2026-01-06 | Eingeleitet | Guggenheim | Buy |
| 2026-01-05 | Eingeleitet | William Blair | Outperform |
| 2025-12-10 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2025-10-08 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-03-31 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-03-26 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-02-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-08-01 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2023-11-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-05-18 | Eingeleitet | Barclays | Overweight |
| 2022-05-17 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-04-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-01-07 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-12-17 | Hochstufung | Cleveland Research | Underperform → Buy |
| 2020-12-16 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-07-28 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-07-16 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-01-08 | Herabstufung | Needham | Hold → Underperform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Eingeleitet | Citigroup | Sell |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-10-09 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2019-07-16 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-06-12 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-01-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-03 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-01-03 | Eingeleitet | Needham | Hold |
| 2018-12-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-11-30 | Herabstufung | Goldman | Neutral → Sell |
| 2018-10-11 | Hochstufung | Cleveland Research | Sell → Neutral |
Alle ansehen
Waters Corp Aktie (WAT) Neueste Nachrichten
Battery safety testing gets a sharper edge with Waters' Coin Cell DSC - AD HOC NEWS
Waters Corp. stock outperforms competitors on strong trading day - MSN
Waters Corporation Stock (US9418481035): Fundamentals and valuation under the microscope - AD HOC NEWS
Waters Launches New Tools As Investors Weigh Biologics And Battery Upside - Yahoo Finance
Waters Corp. stock outperforms competitors despite losses on the day - MarketWatch
Waters Corporation ACQUITY Premier System: UHPLC workhorse for demanding labs - AD HOC NEWS
Calvert U.S. Mid Cap Core Responsible Index Fund's Waters Corp(WAT) Holding History - GuruFocus
Abraham Fortress Fund's Waters Corp(WAT) Holding History - GuruFocus
Top Waters (WAT) Competitors 2026 - MarketBeat
Waters targets earlier thermal runaway detection with whole-cell coin cell differential scanning calorimeter - R&D World
Piper Sandler initiates Waters stock coverage with neutral rating - Investing.com
Piper Sandler initiates Waters stock coverage with neutral rating By Investing.com - Investing.com UK
Waters Corporation Stock (US9418481035): New Coin Cell DSC Launch Puts Materials Analysis In Focus - AD HOC NEWS
Waters Company Profile & Introduction - Moomoo
Waters Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Waters launches coin cell calorimeter for battery testing - Investing.com
Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis - Yahoo Finance
Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis - Finviz
Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis – Company AnnouncementFT.com - Financial Times
2026 Power 100: Udit Batra - Worcester Business Journal
What Just Happened with BD and Waters - Kavout
Waters Corporation $WAT Shares Sold by Bank of New York Mellon Corp - MarketBeat
ETFs Investing in Waters Corporation Stocks - TradingView
Waters Corp. stock underperforms Friday when compared to competitors - MarketWatch
Waters Corporation stock (US9418481035): valuation metrics in focus after recent product news - AD HOC NEWS
Evercore ISI upgrades Waters stock rating on achievable targets - Investing.com
T. Rowe Price Capital Appreciation Fund's Waters Corp(WAT) Holding History - GuruFocus
Waters (WAT) Gains FDA Clearance for Automated Blood Culture Sys - GuruFocus
Waters Corp at Jefferies Global Healthcare Conference in New York Transcript - GuruFocus
Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics - Sharecast.com
Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics – Company AnnouncementFT.com - Financial Times
Kevin Hern acquires Waters Corporation stock through Hern Family Revocable Trust - Investing.com
10,716 Shares in Waters Corporation $WAT Bought by BW Gestao de Investimentos Ltda. - MarketBeat
FDA-cleared blood culture system flags sepsis infections 3 hours faster - Stock Titan
Waters Corp Coverage Assumed by Wolfe Research at Outperform - Moomoo
Wolfe Research initiates Waters stock with Outperform rating By Investing.com - Investing.com India
Waters Corp stock (US94106L1098): new mass spectrometry launch highlights innovation ahead of next e - AD HOC NEWS
Wolfe Research initiates Waters stock with Outperform rating - Investing.com UK
Waters Corporation stock (US9418481035): shares steady after May analyst updates and Q1 earnings - AD HOC NEWS
Waters Corp. stock underperforms Monday when compared to competitors - MarketWatch
Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research - Sharecast.com
New Waters Cyclic IMS P20 maps disease signals in tissue - Stock Titan
Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics - Yahoo Finance
Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks - MSN
Waters Corporation stock (US9418481035): shares hover near recent highs ahead of technical levels - AD HOC NEWS
Waters Corp. Hits Day High with Strong 7.16% Intraday Surge - Markets Mojo
Waters Corp (WAT) Stock Up 7.2% and Still Undervalued -- GF Score: 91/100 - GuruFocus
Waters Corp Stock (WAT) Closed Up by 7.23% on May 28: What Investors Need To Know - TradingKey
Waters Jumps 5.3% Amid Sector-Wide Rally - AlphaStreet
Waters Corporation stock (US9418481035): shares edge higher ahead of Jefferies healthcare conference - AD HOC NEWS
Waters Corporation stock (US9418481035): Stable demand after recent earnings update - AD HOC NEWS
Finanzdaten der Waters Corp-Aktie (WAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.72%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):